'Open-source' initiative aims to save biotech
15 October, 2004 by Graeme O'NeillThis month, an international movement was quietly born -- one that aims to loosen the grip of the world's biggest life science corporations on key enabling technologies and patents for biotechnology R&D.
QIMR, Griffith to collaborate
14 October, 2004 by Melissa TrudingerThe Queensland Institute of Medical Research (QIMR) and Griffith University have entered into a collaboration.
Stronger old guard boosts Intersuisse biotech index
14 October, 2004 by Renate KrelleSeptember was a kind month for the biotechnology sector -- the Intersuisse biotechnology index indicated that the sector more than made up for its loss in August, moving ahead by 4 per cent, almost 1 per cent more than both the All Ordinaries and the Nasdaq.
BresaGen readies to relist
13 October, 2004 by Melissa TrudingerBresaGen (ASX:BGN) is expected to emerge from the shadow of voluntary administration this week, after shareholders voted to approve CBio's acquisition of a 51 per cent interest in the company at a general meeting on Monday.
Aussies need to get smarter about markets: VC
12 October, 2004 by Melissa TrudingerThe lack of use of market intelligence is a key distinction between Australian biotech companies and their counterparts in the US and Europe, Teraform Ventures' Haydn Wright told attendees at a BioMelbourne BioBreakfast this morning.
Reeves a super ambassador for research, says Trounson
12 October, 2004 by Melissa Trudinger'Superman' actor Christopher Reeves, who died yesterday in the US from complications of an infection, was a great ambassador for stem cell research and raised the profile of research around the world, Monash University's Alan Trounson said today.
Poll claims medical research is big issue
11 October, 2004 by Graeme O'NeillYet another public opinion poll has found that Australians want a substantial increase in funding for medical research.
Q-Vis rises from the ashes -- again
08 October, 2004 by Melissa TrudingerFormer WA biotechnology company Q-Vis (ASX:QVL) has risen from the ashes to reinvent itself as Salus Technologies.
Stirling to raise further cash
01 October, 2004 by Renate KrelleStirling Products (ASX:STI) is topping up its coffers with an AUD$1 million placement to clients of stockbroker Taylor Collison. A total of 5 million new shares will be issued at $0.20 per share.
Medical researchers slam Howard's lack of support
29 September, 2004 by Graeme O'NeillOn the eve the Federal election, some of Australia' most famous medical researchers have signed an open letter to Prime Minister John Howard and Opposition Leader Mark Latham asking them to increase funding for medical research.
Combio 2004 - be altruistic, scientists told
27 September, 2004 by Iain ScottEminent burns surgeon Fiona Wood has opened the ComBio 2004 meeting in Perth with an appeal to scientists' altruism.
Labor promises $28 million in graduate subsidies and education
23 September, 2004 by Renate KrelleLabor has announced a $22 million four-year Smart Partnerships program under which 800 graduates would receive subsidised industry placements, and $6 million would be earmarked for educational programs aimed at supporting business ideas with commercial potential.
BTF granted US patent for 'Bioballs'
23 September, 2004 by Renate KrellePrivate Sydney-based biotech BTF has been granted a US patent for its BioBall quality-control product.
Amrad CEO asks for fair deal on options price
21 September, 2004 by Melissa TrudingerIn an unusual move, Amrad (ASX: AML) CEO Pete Smith has asked for options that are due to be granted him after approval at next month's AGM to be granted at the same exercise price as those granted to other employees of the company.
Consultant wins ACT Business Woman of the Year award
17 September, 2004 by Renate KrelleBiotech consultant Dr Lyndal Thorburn has been named the 2004 Telstra Business Woman of the Year for the ACT.
